BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31905339)

  • 21. Drug-induced immune haemolytic anaemia caused by levofloxacin.
    Sukhal S; Gupta S
    Singapore Med J; 2014 Aug; 55(8):e136-8. PubMed ID: 25189315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bosentan-induced immune hemolytic anemia in 17 years old man. A case report.
    Afra F; Mehri M; Namazi S
    Daru; 2021 Jun; 29(1):211-215. PubMed ID: 33486694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-induced immune hemolytic anemia: a retrospective study of 10 cases].
    Bollotte A; Vial T; Bricca P; Bernard C; Broussolle C; Sève P
    Rev Med Interne; 2014 Dec; 35(12):779-89. PubMed ID: 24908632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion med illustrated: Ceftriaxone-induced acute hemolytic anemia.
    Tobian AA; Shirey RS; Savage WJ
    Transfusion; 2010 Aug; 50(8):1647-8. PubMed ID: 20931689
    [No Abstract]   [Full Text] [Related]  

  • 27. Life-threatenting ceftriaxone-induced immune hemolytic anemia in a child with Crohn's disease.
    Mattis LE; Saavedra JM; Shan H; Shirey RS; Powell E; Oliva-Hemker MM
    Clin Pediatr (Phila); 2004 Mar; 43(2):175-8. PubMed ID: 15024441
    [No Abstract]   [Full Text] [Related]  

  • 28. Ceftriaxone-induced hemolysis.
    Guleria VS; Sharma N; Amitabh S; Nair V
    Indian J Pharmacol; 2013; 45(5):530-1. PubMed ID: 24130395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A severe case of cefoxitin-induced immune hemolytic anemia.
    Leaf DE; Langer NB; Markowski M; Garratty G; Diuguid DL
    Acta Haematol; 2010; 124(4):197-9. PubMed ID: 21042010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
    Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
    BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2003 Nov; 43(11):1640-1. PubMed ID: 14617328
    [No Abstract]   [Full Text] [Related]  

  • 34. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
    Garratty G; Postoway N; Schwellenbach J; McMahill PC
    Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-Induced Immune Hemolytic Anemia due to Amoxicillin-Clavulanate: A Case Report and Review.
    Chan Gomez J; Saleem T; Snyder S; Joseph M; Kanderi T
    Cureus; 2020 Jun; 12(6):e8666. PubMed ID: 32699666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftriaxone associated hemolysis.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 1999 May; 111(9):368-70. PubMed ID: 10407998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Linnik YA; Tsui EW; Martin IW; Szczepiorkowski ZM; Denomme GA; Gottschall JL; Hill JM; Dunbar NM
    Transfusion; 2017 Dec; 57(12):2937-2941. PubMed ID: 28905389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'.
    De Wilde M; Speeckaert M; Callens R; Van Biesen W
    Acta Clin Belg; 2017 Apr; 72(2):133-137. PubMed ID: 27169474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.